STOCK TITAN

NewGenIvf has $2.04M in outstanding convertible notes

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

NewGenIvf Group Ltd (NIVF) reported its share counts and outstanding convertible notes as of November 17, 2026. It had 2,790,883 Class A ordinary shares outstanding, including 2,752,036 held by non-affiliates, and 9,136 Class B ordinary shares outstanding.

The company reported convertible notes with an aggregate principal amount of US$2,044,373; US$323,812, representing notes outstanding more than 180 days, was currently eligible for conversion. The remaining notes were subject to escrow or Rule 144 restrictions and were not freely convertible at that time.

Class A ordinary shares outstanding 2,790,883 shares As of November 17, 2026
Class B ordinary shares outstanding 9,136 shares As of November 17, 2026
Class A shares held by non-affiliates 2,752,036 shares As of November 17, 2026
Outstanding convertible notes US$2,044,373 aggregate principal amount As of November 17, 2026
Convertible notes eligible for conversion US$323,812 As of November 17, 2026; notes outstanding more than 180 days
non-affiliate shares financial
"2,752,036 Class A Shares were held by non-affiliates"
convertible notes financial
"outstanding convertible notes with an aggregate principal amount"
Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.
aggregate principal amount financial
"with an aggregate principal amount of US$2,044,373"
The aggregate principal amount is the total amount of money borrowed through a bond or loan that the borrower promises to repay. It’s like the original price tag on a loan or bond, showing how much money is involved in the deal. This number matters because it indicates the size of the debt and helps investors understand the scale of the borrowing.
Rule 144 restrictions regulatory
"remain subject to escrow or Rule 144 restrictions"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did NewGenIvf (NIVF) have outstanding?

NewGenIvf had 2,790,883 Class A ordinary shares and 9,136 Class B ordinary shares outstanding as of November 17, 2026. Of the Class A shares, 2,752,036 were held by non-affiliates.

How much of NewGenIvf’s (NIVF) convertible notes was eligible for conversion?

US$323,812 of the company’s US$2,044,373 aggregate principal amount of outstanding convertible notes was currently eligible for conversion as of November 17, 2026. The eligible notes had been outstanding more than 180 days.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2026

 

Commission File Number: 001-42004

 

NEWGENIVF GROUP LIMITED

(Exact name of registrant as specified in its charter)

 

36/39-36/40, 13th Floor, PS Tower

Sukhumvit 21 Road (Asoke)

Khlong Toei Nuea Sub-district

Watthana District, Bangkok 10110

Thailand

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

 

 

 

EXPLANATORY NOTE

 

Update on Non-Affiliate Shares and Outstanding Convertible Notes

 

NewGenIvf Group Limited (the “Company”) is furnishing the following information regarding its free-trading Class A ordinary shares and outstanding convertible notes as of the dates indicated below.

 

1. Non-Affiliate Shares – Continental Stock Transfer Report

 

According to the Continental Stock Transfer & Trust Company report for NewGenIvf Group Limited (CUSIP G6544E162 / A610ORD), the total number of shares outstanding as of November 17, 2026:

 

●Class A Ordinary Shares: 2,790,883
   
●Class B Ordinary Shares: 9,136

 

Of these outstanding shares, 2,752,036 Class A Shares were held by non-affiliates.

 

2. Outstanding Convertible Notes

 

As of November 17, 2026, the Company has outstanding convertible notes with an aggregate principal amount of US$2,044,373. Of this amount, only US$323,812 (the notes that have been outstanding more than 180 days) is currently eligible for conversion. The remaining notes remain subject to escrow or Rule 144 restrictions and are not freely convertible at this time.

 

This information is being furnished solely for the convenience of investors and does not constitute an offer to sell or a solicitation of an offer to buy any securities.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: November 17, 2026

 

  NewGenIvf Group Limited
     
  By: /s/ Wing Fung Alfred Siu
  Name:  Wing Fung Alfred Siu
  Title: Chairman of the Board and Director

 

2

Keep reading